Your browser doesn't support javascript.
loading
An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19.
Sasidharan, Shan; Nair J, Hareendran; K P, Srinivasakumar; Paul, Jerin; R, Madhu Kumar; Rajendran, Kannan; Saibannavar, Anita Ajit; Nirali, Sonali.
Afiliación
  • Sasidharan S; Department of Research and Development, Pankajakasthuri Herbal Research Foundation, Pankajakasthuri Ayurveda Medical College Campus, Thiruvananthapuram, Kerala, India.
  • Nair J H; Department of Research and Development, Pankajakasthuri Herbal Research Foundation, Pankajakasthuri Ayurveda Medical College Campus, Thiruvananthapuram, Kerala, India.
  • K P S; Institute of Biology and Clinical Research (IBCR), Thiruvananthapuram, Kerala, India.
  • Paul J; Department of Statistics, Vimala College (Autonomous), Thrissur, Kerala, India.
  • R MK; Mysore Medical College and Research Institute, Mysuru, Karnataka, India.
  • Rajendran K; Saveetha Medical College & Hospital, Chennai, India.
  • Saibannavar AA; RCSM Medical College & CPR Hospital, Dasara Chowk, Kolhapur District, Maharashtra, India.
  • Nirali S; Life Point Multi Specialty Hospital, Pune, Maharashtra, India.
PLoS One ; 17(12): e0276773, 2022.
Article en En | MEDLINE | ID: mdl-36472969

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: India